The production of licensed medicines is the main activity of SOTHEMA. Thanks to a portfolio of 35 multinational laboratories, world leaders in the pharmaceutical industry, SOTHEMA registers a permanent increase in the field with the launching of new products that are often therapeutic specialties. SOTHEMA also manufactures medicines under other labels purchased from the principal laboratories. This activity registers an important development thanks to the efforts made by the internal teams of Research and Development of new molecules.
Equipped with the most efficient productive device in the sector, SOTHEMA carries out in favor of national and international laboratories the production of many pharmaceutical specialties. This activity registers an important increase that was backed up with the passing years. SOTHEMA manufactures for the account of many European, American and Moroccan laboratories different pharmaceutical forms including cephalosporin, injectable ampoules and auto-injectable syringes.
SOTHEMA also specializes in manufacturing of generics according to the highest standards and pursuant to applicable regulations.
The wide range of generics manufactured by SOTHEMA includes different types of products, especially injectable products.
Import & Export
SOTHEMA imports licensed medicines and dental products as well as some products froms biotechnology. The importation activity is a result of lack of important quantities justifying local fabrication.
SOTHEMA exports an important part of its production towards Europe, Maghreb, Sub-Saharan Africa and the Persian Gulf. SOTHEMA’s products have a good reputation in many countries in West Africa. Moreover, the free exchange agreements concluded by Morocco are considered by SOTHEMA as important gearing effects of developments of the European and American markets with a big development potential.
- Flexible pouches
- Creams & pomades
- Injectable solutions
- Self injectable syringes
Sothema international footprint
Sothema à l’international